Inventor · disambiguated record
Ross Kedl
Also filed as: KEDL ROSS · KEDL ROSS M
13 granted patents·13 pending applications·440 citations·filing 2003–2019
93Inventor score
Top patents by PatentIndex Score
26 records- 0198US7387271B2Immunostimulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Jun 17, 2008·172 cites·77 claims
- 0297US7993659B2TLR9 agonist and CD40 agonist immunostimulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2008·Granted Aug 9, 2011·64 cites·51 claims
- 0395US7427629B2Immunostimulatory compositions and methods of stimulating an immune response3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Sep 23, 2008·125 cites·5 claims
- 0492US10105426B2Immunostimulatory combinationsDARTMOUTH COLLEGE·Filed 2015·Granted Oct 23, 2018·8 cites·8 claims
- 0592US9161976B2Immunotherapy comprising TLR9 ligand and CD40 ligandDARTMOUTH COLLEGE·Filed 2012·Granted Oct 20, 2015·13 cites·19 claims
- 0692US8329197B2Ex vivo uses of immunostimulatory combinationsNOELLE RANDOLPH J·Filed 2010·Granted Dec 11, 2012·15 cites·12 claims
- 0789US9801947B2Methods and compositions for enhancing immune response3M INNOVATIVE PROPERTIES CO·Filed 2014·Granted Oct 31, 2017·7 cites·20 claims
- 0888US7993648B2Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibodyUNIVERSITRY OF COLORADO·Filed 2007·Granted Aug 9, 2011·21 cites·60 claims
- 0983US8137672B2Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibodyKEDL ROSS·Filed 2011·Granted Mar 20, 2012·7 cites·60 claims
- 1080US8361471B2Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibodyUNIV COLORADO·Filed 2010·Granted Jan 29, 2013·4 cites·16 claims
- 1174US9095608B2Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibodyKEDL ROSS·Filed 2012·Granted Aug 4, 2015·2 cites·66 claims
- 1272US10329338B2Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferonUNIV COLORADO REGENTS·Filed 2015·Granted Jun 25, 2019·1 cites·13 claims
- 1367US2019083592A1Immunostimulatory combinationsDARTMOUTH COLLEGE·Filed 2018·Application pending·0 cites
- 1465US2020087370A1Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunityUNIV COLORADO REGENTS·Filed 2019·Application pending·0 cites
- 1560US2004265351A1Methods and compositions for enhancing immune responseFiled 2004·Application pending·0 cites
- 1660US2017319712A1Methods and compositions for enhancing immune response3M INNOVATIVE PROPERTIES CO·Filed 2017·Application pending·0 cites
- 1759US8961477B2Delivery of immune response modifier compoundsWOLTER JAMES T·Filed 2004·Granted Feb 24, 2015·1 cites·19 claims
- 1857US2005158325A1Immunomodulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 1957US2011182847A1Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimensNOELLE RANDOLPH·Filed 2008·Application pending·0 cites
- 2054US2009004194A1Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunityUNIV COLORADO·Filed 2007·Application pending·0 cites
- 2150US2006045886A1HIV immunostimulatory compositionsKEDL ROSS M·Filed 2005·Application pending·0 cites
- 2249US2006045885A1Method of eliciting an immune response against HIVKEDL ROSS M·Filed 2005·Application pending·0 cites
- 2346US2013302278A1Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimensIMMURX INC·Filed 2013·Application pending·0 cites
- 2446US2005048072A1Immunostimulatory combinations and treatments3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 2541US2010291109A1Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunityKEDL ROSS·Filed 2010·Application pending·0 cites
- 2639US2016015803A1Immunostimulatory combinations and use thereofKEDL ROSS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ross Kedl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →